Cancer

Imaging technique to diagnose melanoma

What you see above is the photo of SolarScan, the new generation of digital diagnostic devices to detect melanoma . Imaging techniques have literally revolutionized the dermatology sector, allowing specialist doctors quick access to data, a better study of the skin and above all the possibility of comparing reports made at different points in time.… Continua a leggere Imaging technique to diagnose melanoma

2022-12-28Marketing

Stem cells from the umbilical cord to save a 2 year old

The doctors at the Dallas hospital have used stem cells , coming from the umbilical cord of the child himself stored in a special bank, to treat a very rare form of cancer which frequently leads to death. The boy, named Caden Ledbetter, suffers from neuroblastoma, a rare malignant embryonic tumor characteristic of this age… Continua a leggere Stem cells from the umbilical cord to save a 2 year old

2022-12-28Marketing

Neuroblastoma, news from research

[Neuroblastoma – microscope photo by Dr. Maria Tsokos, National Cancer Institute] Neuroblastoma is one of the most common tumors of the nervous system in childhood, it is the cause of 15% of childhood cancer deaths, unfortunately those affected by stage IV neuroblastoma it has very little chance of survival which is around 20% . The… Continua a leggere Neuroblastoma, news from research

2022-12-28Marketing

Breast cancer early detection starts at home

Early detection of breast cancer , or mammary carcinoma (malignant tumor of the glandular tissue of the breast), is possible if a woman pays attention to changes in her breasts over time. The initial stage is represented by a soft or hard lump , fixed or mobile, painful or not, which does not disappear and… Continua a leggere Breast cancer early detection starts at home

2022-12-28Marketing

Revolutionary molecule against lung cancer

Sadly aware of the fact that against lung cancer, which currently affects about 37,000 people every year in Italy alone, there are still few effective treatments, the pharmaceutical company Pharmion has announced the launch of an international phase III study on the treatment of small cell lung cancer with amrubicin (a new fully synthetic anthracycline).… Continua a leggere Revolutionary molecule against lung cancer

2022-12-28Marketing